Publikation

Following the adverse outcome pathway from micronucleus to cancer using H2B-eGFP transgenic healthy stem cells

Bastian Niklas Hölzel, Kurt Pfannkuche, Bernhard Allner, Hans Thomas Allner, Jürgen Hescheler, Daniel Derichsweiler, Henner Hollert, Andreas Schiwy, Julia Brendt, Michael Schaffeld, Alexander Froschauer & Petra Stahlschmidt-Allner Following the adverse outcome pathway from micronucleus to cancer using H2B-eGFP transgenic healthy stem cells. Arch Toxicol 94, 3265–3280 (2020).

Exceptional Paper Award

Our article on kinetic vitellogen determination was honored as one of the top 10 exceptional ET&C publications.

 
 

We thank the author team and Dr. Reinhard Möller (TECOmedicalGroup) cordially for patience, perseverance and many years of development cooperation, ultimately resulting in this scientifically convincing study. The study was funded under the ZIM program of the Ministry of Economic Affairs KF 006160 2MD 8.

Aarbergen den 22.06.2017

Bernhard Allner
Petra Stahlschmidt-Allner